Infinitopes

Positioned to deliver revolutionary cancer vaccines

Oxford, United Kingdom · $35.1M raised

Headquarters
Oxford
Employees
11–50
Business Model
B2B
Total Funding
$35.1M
Last Round
$15.4M SeedJan 2025
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Infinitopes develops an off-the-shelf cancer vaccine strategy through its Precision Immunomics platform, designed as a rapid, cost-effective and scalable precision immunotherapy approach for broad patient populations. It combines immunopeptidomics, bespoke AI/ML workflows, clinically validated vectors and patient stratification to address the costs, delays and clinical complexity of full personalisation. The platform also integrates advanced LC/MS and biological validation to discover tumour-specific antigens.

Summary

Infinitopes is a Biotech company based in Oxford, United Kingdom. It has raised $35.1M in total across 2 rounds, most recently a $15.4M Seed round in Jan 2025. Investors include octopus investments, Amplify Partners and Kindred Capital.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundJan 2025
$15.4M

Sign up to see all 2 events

Funding: Seed. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Infinitopes on Indexed.vc
<a href="https://indexed.vc/companies/infinitopes"><img src="https://indexed.vc/api/badge/company/infinitopes" alt="Infinitopes on Indexed.vc" width="260" height="76" /></a>